These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 11071880
1. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha. Cook WS, Yeldandi AV, Rao MS, Hashimoto T, Reddy JK. Biochem Biophys Res Commun; 2000 Nov 11; 278(1):250-7. PubMed ID: 11071880 [Abstract] [Full Text] [Related]
3. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Nemali MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. Cancer Res; 1988 Sep 15; 48(18):5316-24. PubMed ID: 2900680 [Abstract] [Full Text] [Related]
4. Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation. Rangwala SM, O'Brien ML, Tortorella V, Longo A, Loiodice F, Noonan DJ, Feller DR. Chirality; 1997 Sep 15; 9(1):37-47. PubMed ID: 9094202 [Abstract] [Full Text] [Related]
5. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease. Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH, Kim JY, Park JJ, Kim JS, Bak YT, Byun KS, Lee CH. J Gastroenterol Hepatol; 2004 Jul 15; 19(7):799-804. PubMed ID: 15209628 [Abstract] [Full Text] [Related]
13. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level. Lee GY, Kim NH, Zhao ZS, Cha BS, Kim YS. Biochem J; 2004 Mar 15; 378(Pt 3):983-90. PubMed ID: 14641110 [Abstract] [Full Text] [Related]
14. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver. Romics L, Kodys K, Dolganiuc A, Graham L, Velayudham A, Mandrekar P, Szabo G. Hepatology; 2004 Aug 15; 40(2):376-85. PubMed ID: 15368442 [Abstract] [Full Text] [Related]
15. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats. Rao MS, Papreddy K, Musunuri S, Okonkwo A. In Vivo; 2002 Aug 15; 16(2):145-52. PubMed ID: 12073774 [Abstract] [Full Text] [Related]
16. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding. Sugden MC, Bulmer K, Gibbons GF, Holness MJ. Arch Biochem Biophys; 2001 Nov 15; 395(2):246-52. PubMed ID: 11697863 [Abstract] [Full Text] [Related]
17. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH, Kim A, Yeon JE. J Gastroenterol Hepatol; 2008 Jan 15; 23(1):102-9. PubMed ID: 18171348 [Abstract] [Full Text] [Related]